Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CSL Behring
Age
0–2
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Infants who received more than one dose of IgG by the subcutaneous route before the age of two years.
Consent of parent/guardian if required by institution/IRB.
You may not be if
Infants with protein losing conditions such as lymphangiectasis, nephrosis, S/P cardio-thoracic surgery requiring drainage tubes for more than 48 hrs, protein losing enteropathy.
Concomitant treatment with plasma, other blood products or IGIV while on SCIG.
Lack of consent by parent/guardian (if required by Institution/IRB).
Any other condition or treatment which, in the opinion of the local investigator, would interfere with obtaining valid results for that subject.
Clareo Health | Retrospective Chart Review of Subcutaneous IgG Use in Infants
